[1] Dietz V, Cutts F. The use of mass campaigns in the expanded program on immunization:
a review of reported advantages and disadvantages. Int J Health Serv
1997;27:767–90.
[2] NokesDJ, Enquselassie F, NigatuW, Vyse AJ, Cohen BJ, BrownDWG, et al. Has oral
fluid the potential to replace serum for the evaluation of population immunity
levels? A study of measles, rubella and hepatitis B in rural Ethiopia. BullWorld
Health Organ 2001;79(7):588–95.
[3] Nigatu W, Nokes DJ, Enquselassie F, Brown DWGF, Cohen BJ, Vyse A, et al.
Detection of measles specific IgG in oral fluid using an FITC/anti-FITC IgG
capture enzyme linked immunosorbent assay (GACELISA). J Virol Methods
1999;83(1–2):135–44.
[4] Kremer JR, Muller CP. Evaluation of commercial assay detecting specific
immunoglobulin G in oral fluid for determining measles immunity in vaccines.
Clin Diagn Lab Immunol 2005;12(5):668–70.
[5] Enquselassie F, AyeleW, Dejene A, Messele A, Abebe A, Cutts FT, et al. Seroepidemiology
of measles inAddis Ababa. Ethiopia:implications for control through
vaccination. Epidemiol Infect 2003;130(3):507–19.
[6] Central Statistical Authority. The 1994 population and housing census of
Ethiopia: results for Oromia region, Volume II. Analytical report. Addis Ababa,
1998.
[7] Vyse AJ, Cohen BJ, Ramsay ME. A comparison of oral fluid collection devices
for use in the surveillance of virus diseases in children. Public Health
2001;115(3):201–7.
[8] Nokes DJ, Enquselassie F, Vyse A, Nigatu W, Cutts FT, Brown DWG. An
evaluation of oral-fluid collection devices for the determination of rubella antibody
status in a rural Ethiopian community. Trans Roy Soc Trop Med Hyg
1998;92(6):679–85.
[9] Dean JA, Denis C, Donald CS, Karl AB, Thomas GA, Dean AG. Epi Info, Version
6.04: aword processing, database, and statistical program for epidemiology on
microcomputers. Atlanta, GA, USA: Centers for Disease Control and Prevention;
1994.
[10] Stata Corp. Stata statistical software: release 8. College Station, TX: Stata Corporation;
2003.
[11] Nokes DJ, Nigatu W, Abebe A, Messele T, Dejene A, Enqueslassie F, et al. A
comparison of oral fluid and serum for the detection of rubella-specific antibodies
in a community study in Addis Ababa, Ethiopia. Trop Med Int Health
1998;3(4):258–67.
[12] Cohen BJ, Parry RP, Doblas D,Warrener L, Andrews N, Brown D. Measles immunity
testing: comparison of two measles IgG ELISAs with plaque reduction
neutralization assay. J Virol Methods 2006;131:209–12.
[13] Nokes DJ, Swinton J. Vaccination in pulses: a strategy for global eradication of
measles and polio? Trends Microbiol 1997;5(1):14–9.
[14] Cutts F, Steinglass R. Should measles be eradicated? Brit Med J
1998;316:757–65.
[15] Nokes DJ, Anderson RM. The use of mathematical models in the epidemiological
study of infectious diseases and in the design of mass immunization
programmes. Epidemiol Infect 1988;101(1):1–20.
[16] Nigatu W, Nokes DJ, Afework A, Brown DWG, Cutts FT, Jin L. Serological and
molecular epidemiology of measles virus outbreaks reported in Ethiopia during
2000–2004. J Med Virol 2006;78:1648–55.
[17] WHO-AFRO. AFRO Measles Surveillance Feedback Bulletin; November 2007.
[18] Borus PK. Missed opportunities and inappropriately given vaccines reduce
immunisation coverage in facilities that serve slum areas of Nairobi. East Afr
Med J 2004;81(3):124–9.